Leap Therapeutics, Inc. - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi LPTX

Logo grafis Leap Therapeutics Inc (LPTX)

Leap Therapeutics, Inc. (LPTX) is developing cancer immunotherapy through strategic partnerships to improve patient survival rates. The EBITDA_Co trend clearly demonstrates the current financial standing, where the metric value stands at . The business relies on grants as there are no sales. High clinical trial costs create a liquidity deficit, forcing the company to constantly raise external capital.

Bathi sadurunge mbayar bunga, pajak, lan amortisasi: Leap Therapeutics, Inc. (LPTX) kanggo 04.07.2022 - 16.11.2026

Leap Therapeutics Inc - rincian analitis lan metrik utama (LPTX)

- nilai pasar lan prakiraan target analis:
Analisis kabeh metrik perusahaan:Leap Therapeutics - LPTX
Produk seri Leap Therapeutics

The market assesses the potential of Leap Therapeutics, Inc. (LPTX) through the lens of intellectual property for DKN-01 antibodies, which solidify the company's dominance in the immuno-oncology segment. By analyzing the annual EBITDA, an investor sees the net cash balance from operating activities excluding depreciation and taxes, allowing for an objective assessment of current business efficiency and the stability of its financial foundation.

Pesaing Leap Therapeutics, Inc. (LPTX)

ImmunityBio (IBRX) - Bathi sadurunge bunga, pajak, lan amortisasi|IMCR: Bathi operasional sadurunge ngurangi amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi JANX (Janux Therapeutics, Inc.)|RCUS: Bathi operasional EBITDA|ZYME - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi tangotx.com|Bathi operasional sadurunge ngurangi amortisasi iovance.com (IOVA)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Immatics NV (IMTX)|Bathi operasional sadurunge ngurangi amortisasi Xencor Corp XNCR|Compass Therapeutics Inc - Bathi operasional sadurunge ngurangi amortisasi|Bathi operasional EBITDA Replimune Inc. REPL|LYEL - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|IPHA (innate-pharma.com) - Bathi operasional sadurunge amortisasi|pyxisoncology.com (PYXS) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge bunga, pajak, lan amortisasi Compugen Ltd. (CGEN)|Bathi operasional sadurunge ngurangi amortisasi IOBT|STRO - Bathi operasional sadurunge potongan amortisasi|Bathi operasional sadurunge ngurangi amortisasi INKT (MiNK)|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi HOWL|Bathi operasional EBITDA IMMX (Immix Biopharma, Inc.)|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi ALXO|CUE - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge bunga, pajak, lan amortisasi PDS Biotechnology Corporation|Sonnet BioTherapeutics Holdings Inc. (SONN) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|MAIA Biotechnology - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|LIMN (liminatuspharma.com) - Bathi operasional EBITDA|Bathi operasional EBITDA lavatherapeutics.com|Bathi sadurunge mbayar bunga, pajak, lan amortisasi NextCure (NXTC)|INTS: Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Sensei Biotherapeutics, Inc. - Bathi operasional sadurunge ngurangi amortisasi|Theriva Biologics (TOVX) - Bathi sadurunge bunga, pajak, lan amortisasi|gritstonebio.com - Bathi operasional EBITDA|KA (Kineta) - Bathi operasional sadurunge amortisasi|NEXI: Bathi operasional EBITDA|Turnstone Biologics Corporation (TSBX) - Bathi operasional EBITDA|VCNX (vaccinex.com) - Bathi operasional EBITDA|HARP: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi